重症肌无力住院与死亡趋势:来自美国两个国家数据集的分析
研究利用美国全国住院患者样本和Medicare有限数据集,分析2010至2019年成人重症肌无力(MG)住院、再入院及死亡趋势。成人MG住院率年均增长4.9%,其中MG危象增长6.8%;再入院率约20%,院内死亡率平均1.8%;65岁及以上患者院内死亡率平均5.0%,住院率年增5.2%。
要点
- 成人MG住院率2010至2019年年均增长4.9%,MG危象年均增长6.8%。
- 再入院率各年约20%,院内死亡率平均1.8%。
- 65岁及以上患者住院率年增5.2%,院内死亡率平均5.0%。
核心结论
- 住院率上升提示MG相关负担加重,尤其在老年人群中;再入院率和死亡率保持稳定,但住院率上升意味着再入院和死亡的绝对数也在增加。
- 老年住院MG患者的死亡率显著高于全部患者。
研究设计与样本
- 研究使用美国全国住院患者样本(NIS)分析18岁及以上成人MG住院和院内死亡趋势,使用Medicare有限数据集分析65岁及以上按服务收费受益人住院、住院时长、再入院和出院后30天死亡,研究期为2010至2019年。
- NIS分析纳入19,715例独特成人患者和56,822次住院。
主要发现
- 2010至2019年成人MG住院率年均增长4.9%(MG非危象:4.4%;MG危象:6.8%;所有p < 0.001)。
- MG危象和非危象住院的再入院率每个研究年份均约20%;院内死亡率平均1.8%。
- 65岁及以上患者总住院、非危象住院和危象住院的年均增长率分别为5.2%、4.2%和7.7%(所有p < 0.001)。
- 平均住院时长在研究期间稳定在11.3至13.1天,但MG危象住院 consistently 更长。
- 65岁及以上患者死亡率高于全部患者,每个研究年份平均5.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Myasthenia gravis (MG) is a rare neuromuscular disorder where IgG antibodies damage the communication between nerves and muscles, leading to muscle weakness that can be severe and have a significant impact on patients' lives. MG exacerbations include myasthenic crisis with respiratory failure, the most serious manifestation of MG. Recent studies have found MG prevalence increasing, especially in older patients. This study examined trends in hospital admissions and in-hospital mortality for adult patients with MG and readmissions and postdischarge mortality in older (65 years or older) adults with MG. METHODS: Data from the Nationwide Inpatient Sample (NIS), an all-payer national database of hospital discharges, were used to characterize trends in hospitalizations and in-hospital mortality related to MG exacerbations and MG crisis among adult patients aged 18 years or older. The Medicare Limited Data Set, a deidentified, longitudinal research database with demographic, enrollment, and claims data was used to assess hospitalizations, length of stay (LOS), readmissions, and 30-day postdischarge mortality among fee-for-service Medicare beneficiaries aged 65 years or older. The study period was 2010-2019. Multinomial logit models and Poisson regression were used to test for significance of trends. RESULTS: Hospitalization rates for 19,715 unique adult patients and 56,822 admissions increased from 2010 to 2019 at an average annualized rate of 4.9% (MG noncrisis: 4.4%; MG crisis: 6.8%; all p < 0.001). Readmission rates were approximately 20% in each study year for both crisis and noncrisis hospitalizations; the in-hospital mortality rate averaged 1.8%. Among patients aged 65 years or older, annualized increases in hospitalizations were estimated at 5.2%, 4.2%, and 7.7% for all, noncrisis, and crisis hospitalizations, respectively (all p < 0.001). The average LOS was stable over the study period, ranging from 11.3 to 13.1 days, but was consistently longer for MG crisis admissions. Mortality among patients aged 65 years or older was higher compared with that in all patients, averaging 5.0% across each of the study years. DISCUSSION: Increasing hospitalization rates suggest a growing burden associated with MG, especially among older adults. While readmission and mortality rates have remained stable, the increasing hospitalization rates indicate that the raw numbers of readmissions-and deaths-are also increasing. Mortality rates are considerably higher in older patients hospitalized with MG.
引用
- Habib AA, Sacks N, Cool C, et al. Hospitalizations and Mortality From Myasthenia Gravis: Trends From 2 US National Datasets. Neurology. 2023. PMID: 38165317. doi:10.1212/WNL.0000000000207863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。